E-PaperDr Reddys Laboratories Q2 Results
- BSE: 500124
- NSE: DRREDDY
- ISIN: INE089A01023
- Sector: Biotechnology & Drugs
BSE
6,829.75
12.60 (0.18%)
12.60 (0.18%)Volume2.48 K
Updated: Thu 25 Jul, 2024 | 12:15:25
NSE
6,832.812.65 (0.19%)
12.65 (0.19%)Volume1.45 L
Updated: Thu 25 Jul, 2024 | 12:07:46
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Dr Reddys Laboratories Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 23 | Jun 23 | QoQ Comp |
|---|---|---|---|
| Total Revenue | 6,902.60 | 6,757.90 | 2.14% |
| Selling/ General/ Admin Expenses Total | 2,885.80 | 2,757.10 | 4.67% |
| Depreciation/ Amortization | 375.50 | 353.30 | 6.28% |
| Total Operating Expense | 5,171.40 | 4,995.10 | 3.53% |
| Operating Income | 1,731.20 | 1,762.80 | -1.79% |
| Net Income Before Taxes | 1,916.70 | 1,850.00 | 3.61% |
| Net Income | 1,482.20 | 1,405.00 | 5.49% |
| Diluted Normalized EPS | 84.60 | 81.95 | 3.24% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01RNFI Services IPO booked over 221 times on the third bidding day, NIIs steal the show; check GMP
3 min read24 Jul 2024 - Markets
02Wall Street today: Lacklustre Tesla & Alphabet results drag Nasdaq down nearly 2%
2 min read24 Jul 2024 - Markets
03Buy or sell: Vaishali Parekh recommends three stocks to buy today — July 25
2 min read08:32 AM IST